Thyrotropin

• USES TAKE 15 MINUTES BEFORE MEALS

DIRECTIONS Take 15 minutes before meals Adults : 20 drops in a little water, 2 times per day

Stop use and ask doctor if symptoms persist more than 5 days. If pregnant or breast-feeding ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Contains ethyl alcohol 30%

• Nov 30, 1998BLABLA020898Genzyme

1. 1Nausea12713%
2. 2Headache828.1%
3. 3Fatigue818.0%
4. 4Off Label Use727.1%
5. 5Vomiting515.1%
6. 6Malaise434.3%
7. 7Dizziness414.1%
8. 8Pain404.0%
9. 9Drug Ineffective363.6%
10. 10Blood Thyroid Stimulating Hormone Decreased282.8%
11. 11Asthenia262.6%
12. 12Pyrexia262.6%
13. 13Diarrhoea242.4%
14. 14Arthralgia232.3%
15. 15Drug Administered At Inappropriate Site232.3%

Recent PubMed references pinned to Thyrotropin as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Postoperative stimulated thyroglobulin and the ps-tg/TSH ratio enhance the 2025 ATA risk stratification for predicting radioiodine response in papillary thyroid carcinoma.
  Annals of medicine · 2026 · Ran B, Zhang H, Li Y, et al.
  PMID 42252965DOI 10.1080/07853890.2026.2657641
• Preparation, characterization, and calibration of two fundamental reagents for the immunoradiometric (IRMA-125I) thyroid-stimulating hormone assay.
  Radiation protection dosimetry · 2026 · Hamdi N, Asselah D, Nouri R, et al.
  PMID 42233298DOI 10.1093/rpd/ncaf187
• Single 0.9-mg intramuscular rhTSH dose achieves target TSH levels in differentiated thyroid carcinoma.
  Endocrine · 2026 · Leite PHF, Pires MC, Penna GC, et al.
  PMID 42228192DOI 10.1007/s12020-026-04671-y
• Behavior of serum thyroglobulin in relation to thyroid function under low-thyrotropin conditions in general practice.
  Frontiers in endocrinology · 2026 · Sazumi Y, Soejima Y, Otsuka Y, et al.
  PMID 42222078DOI 10.3389/fendo.2026.1756863
• Association of Subclinical Hypothyroidism with Reproductive, Metabolic, and Molecular Dysfunction in Polycystic Ovary Syndrome.
  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP · 2026 · Iram A, Jafri SA, Majeed KA, et al.
  PMID 42219828DOI 10.29271/jcpsp.2026.06.719
• Efficacy and safety of 125I seed implantation combined with thyroid-stimulating hormone suppression therapy in cervical lymph node metastases of differentiated thyroid carcinoma.
  Frontiers in endocrinology · 2026 · Ruan Y, Yuan H, Zheng F, et al.
  PMID 42181184DOI 10.3389/fendo.2026.1747769
• Third-trimester estradiol is associated with isolated maternal hypothyroxinemia and attenuated TSH-FT4 coupling: evidence from rats and human astrocytes.
  Frontiers in endocrinology · 2026 · Xu Y, Wang Z, Cai Q, et al.
  PMID 42147109DOI 10.3389/fendo.2026.1795855
• TSH promotes chemerin/CMKLR1-cAMP/ERK-DIO2 signaling in primary rat ependymal cells in vitro.
  Journal of molecular endocrinology · 2026 · Ning X, Guo D, Huang Q, et al.
  PMID 42126300DOI 10.1530/JME-26-0028

The 10 most recently updated of 192 ClinicalTrials.gov registrations naming Thyrotropin as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• Searching a Dysfunction of Corticotropic & Thyrotropin Axis During the Acute Phase of a Subarachnoid Hemorrhage Secondary to Spontaneous Rupture of Cerebral Aneurysm
  Completed · Interventional · 26 enrolled · Rennes University Hospital
  NCT03655509updated 2026-06-11
• A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
  Recruiting · Phase 2 · Interventional · 210 enrolled · Immunovant Sciences GmbH
  NCT07018323updated 2026-06-08
• A Long-Term Extension Study of IMVT-1402 in Adult Participants With Graves' Disease (GD)
  Enrolling by invitation · Phase 2 · Interventional · 372 enrolled · Immunovant Sciences GmbH
  NCT07286006updated 2026-06-08
• The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
  Recruiting · Phase 2 · Interventional · 30 enrolled · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  NCT03841617updated 2026-06-05
• Natural History of Thyroid Function Disorders
  Recruiting · Observational · 2,500 enrolled · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  NCT00001159updated 2026-06-01
• Comorbidities in Type 2 Diabetes Mellitus
  Completed · Interventional · 295 enrolled · New Valley University
  NCT05874141updated 2026-05-26
• Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI)
  Not yet recruiting · Observational · 440 enrolled · Zealand University Hospital
  NCT07200739updated 2026-05-05
• Better Understanding of Fatigue After STroke
  Recruiting · Interventional · 250 enrolled · Brugmann University Hospital
  NCT06292377updated 2026-03-30
• Efficacy of MEK (Trametinib) and BRAFV600E (Dabrafenib) Inhibitors With Radioactive Iodine (RAI) for the Treatment of Refractory Metastatic Differentiated Thyroid Cancer
  Completed · Phase 2 · Interventional · 40 enrolled · Gustave Roussy, Cancer Campus, Grand Paris
  NCT03244956updated 2026-03-23
• Frequency of Fibromyalgia Syndrome in Elderly Patients Aged 80 and Above and Its Relationship With Geriatric Parameters
  Completed · Observational · 420 enrolled · Sultan 1. Murat State Hospital
  NCT06969716updated 2026-03-20

Frequently asked questions

What is Thyrotropin used for?

According to FDA labeling, Thyrotropin carries indications including: USES TAKE 15 MINUTES BEFORE MEALS. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.

What class of drug is Thyrotropin?

Thyrotropin is classified as Tests for thyreoidea function.